Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
53.4M
-
Number of holders
-
45
-
Total 13F shares, excl. options
-
17.2M
-
Shares change
-
+207K
-
Total reported value, excl. options
-
$114M
-
Value change
-
+$1.5M
-
Number of buys
-
20
-
Number of sells
-
-17
-
Price
-
$6.65
Significant Holders of scPharmaceuticals Inc. - Common Stock (SCPH) as of Q1 2021
49 filings reported holding SCPH - scPharmaceuticals Inc. - Common Stock as of Q1 2021.
scPharmaceuticals Inc. - Common Stock (SCPH) has 45 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17.2M shares
of 53.4M outstanding shares and own 32.14% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (4.8M shares), 5AM Venture Management, LLC (3.83M shares), RA CAPITAL MANAGEMENT, L.P. (2.73M shares), Ikarian Capital, LLC (1.31M shares), AIGH Capital Management LLC (855K shares), GOLDMAN SACHS GROUP INC (649K shares), VANGUARD GROUP INC (643K shares), Alyeska Investment Group, L.P. (356K shares), BlackRock Inc. (329K shares), and Worth Venture Partners, LLC (214K shares).
This table shows the top 45 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.